Eli Lilly starts construction of a $5bn manufacturing site near Richmond, Virginia
FROM THE WIRE · FINANCE.YAHOO.COM
Eli Lilly (NYSE:LLY) has started construction on a US$5b fully integrated manufacturing site near Richmond, Virginia, focused on next-generation cancer and autoimmune medicines. The Richmond facility is planned as Lilly's first U.S. site to house both active ingredient…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA plant investment of this size at a large pharma group is relevant for the stock but remains ordinary news flow.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Lilly has started construction of a $5bn integrated manufacturing site near Richmond, Virginia.
- 02The site targets next-generation cancer and autoimmune medicines.
- 03Lilly also signed a collaboration with METiS TechBio to apply AI to drug delivery platforms.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets